Joris Langedijk

446 total citations
5 papers, 321 citations indexed

About

Joris Langedijk is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and Health. According to data from OpenAlex, Joris Langedijk has authored 5 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pediatrics, Perinatology and Child Health, 4 papers in Economics and Econometrics and 1 paper in Health. Recurrent topics in Joris Langedijk's work include Pharmaceutical Economics and Policy (4 papers), Pharmaceutical studies and practices (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Joris Langedijk is often cited by papers focused on Pharmaceutical Economics and Policy (4 papers), Pharmaceutical studies and practices (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Joris Langedijk collaborates with scholars based in Netherlands. Joris Langedijk's co-authors include Aukje K. Mantel‐Teeuwisse, Marie-Hélène D.B. Schutjens, Liset van Dijk, Marcia Vervloet, Hubert G. M. Leufkens, Cees Neef, Hans C. Ebbers, Jarno Hoekman, Jacoline C. Bouvy and Wouter Boon and has published in prestigious journals such as Drug Discovery Today, European Journal of Clinical Pharmacology and European Journal of Hospital Pharmacy.

In The Last Decade

Joris Langedijk

5 papers receiving 315 citations

Peers

Joris Langedijk

MB

PPCH

CTM

EE

ONCOL

Marie-Hélène D.B. Schutjens Netherlands

Yasuo Kodama Japan

Stephanie Van Bebber United States

Christopher‐Paul Milne United States

Marisa Papaluca‐Amati Netherlands

Christina Mitropoulou Greece

Gregory McInnes United States

Viktoriia Starokozhko Netherlands

Gregory Koytiger Israel

Cathelijne H. van der Wouden Netherlands

Marie-Hélène D.B. Schutjens Netherlands

Joris Langedijk

102 ×1.0

MB

44 ×0.6

PPCH

72 ×1.0

CTM

45 ×0.7

EE

29 ×0.9

ONCOL

Citations per year, relative to Joris Langedijk Joris Langedijk (= 1×) peers Marie-Hélène D.B. Schutjens

Countries citing papers authored by Joris Langedijk

Since Specialization

Citations

This map shows the geographic impact of Joris Langedijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joris Langedijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joris Langedijk more than expected).

Fields of papers citing papers by Joris Langedijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joris Langedijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joris Langedijk. The network helps show where Joris Langedijk may publish in the future.

Co-authorship network of co-authors of Joris Langedijk

This figure shows the co-authorship network connecting the top 25 collaborators of Joris Langedijk. A scholar is included among the top collaborators of Joris Langedijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joris Langedijk. Joris Langedijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Vervloet, Marcia, et al.. (2017). Study on off-label use of medicinal products in the European Union.. Data Archiving and Networked Services (DANS). 49 indexed citations

2.

Langedijk, Joris, et al.. (2016). Legislation on the preparation of medicinal products in European pharmacies and the Council of Europe Resolution. European Journal of Hospital Pharmacy. 24(4). 224–229. 19 indexed citations

3.

Langedijk, Joris, et al.. (2015). Extensions of indication throughout the drug product lifecycle: a quantitative analysis. Drug Discovery Today. 21(2). 348–355. 22 indexed citations

4.

Langedijk, Joris, et al.. (2015). Drug repositioning and repurposing: terminology and definitions in literature. Drug Discovery Today. 20(8). 1027–1034. 227 indexed citations

5.

Ebbers, Hans C., Joris Langedijk, Jacoline C. Bouvy, et al.. (2015). An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe. European Journal of Clinical Pharmacology. 71(10). 1237–1244. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact